Literature DB >> 26341913

A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia.

M C Alanin1, K G Nielsen2, C von Buchwald3, M Skov2, K Aanaes3, N Høiby4, H K Johansen5.   

Abstract

In patients with primary ciliary dyskinesia (PCD), impaired mucociliary clearance leads to an accumulation of secretions in the airways and susceptibility to repeated bacterial infections. The primary aim of this study was to investigate the bacterial flora in non-chronic and chronic infections in the lower airways of patients with PCD. We retrospectively reviewed the presence of bacteria from patients with PCD during an 11-year period and genotyped 35 Pseudomonas aeruginosa isolates from 12 patients with chronic infection using pulsed-field gel electrophoresis. We identified 5450 evaluable cultures from 107 patients with PCD (median age 17 years, range 0-74 years) (median age at diagnosis 7.8 years, range 0-63 years). Haemophilus influenzae was the most frequent microorganism. Other common pathogens were P. aeruginosa, Streptococcus pneumoniae, Moraxella catarrhalis and Staphylococcus aureus. The number of patients colonized with P. aeruginosa at least once varied from 11 to 44 patients (15-47%) annually, and 42 patients (39%) met the criteria for chronic infection at least once. Pseudomonas aeruginosa was more frequently isolated in teenagers and adults than children (p 0.02) and the prevalence was significantly lower in patients with preschool (<6 years) PCD diagnosis (p 0.04). Ten out of 12 patients (83%) were chronically infected with a unique clone-type of P. aeruginosa. No sharing of clone-types or patient-to-patient transmission was observed. In conclusion, PCD patients were infected by a unique set of bacteria acquired in an age-dependent sequence. Pseudomonas aeruginosa frequently colonizes the lower respiratory tract and the incidence of chronic infection was higher than previously reported.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ciliary motility disorders; Kartagener's syndrome; Pseudomonas aeruginosa; mucociliary clearance; pulse-field gel electrophoresis

Mesh:

Year:  2015        PMID: 26341913     DOI: 10.1016/j.cmi.2015.08.020

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  28 in total

1.  Cephalosporin-3'-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms.

Authors:  Samuel A Collins; Michael J Kelso; Ardeshir Rineh; Nageshwar R Yepuri; Janice Coles; Claire L Jackson; Georgia D Halladay; Woolf T Walker; Jeremy S Webb; Luanne Hall-Stoodley; Gary J Connett; Martin Feelisch; Saul N Faust; Jane S A Lucas; Raymond N Allan
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.

Authors:  Kristi L Higgins; Cady Noda; Jeremy S Stultz
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 3.  Sinus bacteriology in patients with cystic fibrosis or primary ciliary dyskinesia: A systematic review.

Authors:  Maria E Møller; Mikkel C Alanin; Christian Grønhøj; Kasper Aanæs; Niels Høiby; Christian von Buchwald
Journal:  Am J Rhinol Allergy       Date:  2017-09-01       Impact factor: 2.467

Review 4.  Primary Ciliary Dyskinesia.

Authors:  Michael R Knowles; Maimoona Zariwala; Margaret Leigh
Journal:  Clin Chest Med       Date:  2016-06-30       Impact factor: 2.878

Review 5.  Understanding Primary Ciliary Dyskinesia and Other Ciliopathies.

Authors:  Amjad Horani; Thomas W Ferkol
Journal:  J Pediatr       Date:  2020-11-23       Impact factor: 4.406

6.  Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype.

Authors:  Stephanie D Davis; Margaret Rosenfeld; Hye-Seung Lee; Thomas W Ferkol; Scott D Sagel; Sharon D Dell; Carlos Milla; Jessica E Pittman; Adam J Shapiro; Kelli M Sullivan; Keith R Nykamp; Jeffrey P Krischer; Maimoona A Zariwala; Michael R Knowles; Margaret W Leigh
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 30.528

Review 7.  Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.

Authors:  Christiaan Dm Wijers; James F Chmiel; Benjamin M Gaston
Journal:  Chron Respir Dis       Date:  2017-03-06       Impact factor: 2.444

Review 8.  Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies.

Authors:  Virginia Mirra; Claudius Werner; Francesca Santamaria
Journal:  Front Pediatr       Date:  2017-06-09       Impact factor: 3.418

9.  Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.

Authors:  Helene E Kobbernagel; Frederik F Buchvald; Eric G Haarman; Carmen Casaulta; Samuel A Collins; Claire Hogg; Claudia E Kuehni; Jane S Lucas; Heymut Omran; Alexandra L Quittner; Claudius Werner; Kim G Nielsen
Journal:  BMC Pulm Med       Date:  2016-07-22       Impact factor: 3.317

10.  Bacterial evolution in PCD and CF patients follows the same mutational steps.

Authors:  Lea M Sommer; Mikkel Christian Alanin; Rasmus L Marvig; Kim Gjerum Nielsen; Niels Høiby; Christian von Buchwald; Søren Molin; Helle Krogh Johansen
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.